Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Esketamine and Prolonged Exposure for PTSD: A Proof-of-Concept Clinical Trial

NCT06795659 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT06795659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Esketamine and Prolonged Exposure for PTSD: A Proof-of-Concept Clinical Trial
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Phase 1/2
Overall status
Completed
Start date
June 9, 2025
Completion date
January 16, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder ptsd